メインコンテンツにスキップ
検索

薬事戦略

Category / type

Everything you need to know about ILAP 2.0
ILAP 2.0について知っておくべき全て ホワイトペーパー

Everything you need to know about ILAP 2.0

This white paper share’s key insights on the relaunch of MHRA’s Innovative Licensing and Access Pathway (ILAP).
Everything you need to know about ILAP 2.0
ILAP 2.0について知っておくべき全て ホワイトペーパー

Everything you need to know about ILAP 2.0

This white paper share’s key insights on the relaunch of MHRA’s Innovative Licensing and Access Pathway (ILAP).
Protect Confidential Information in Investigational Drug Submissions
Protect Confidential Information in Investigational Drug SubmissionsBlog

Protect Confidential Information in Investigational Drug Submissions

2025年3月20日 Health regulatory agencies require pharmaceutical companies to protect study participants’ personal information (PI) within regulatory drug submissions.…

All resources heading

ニュースレターを購読

今すぐ登録:医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software